A Comparison of Clinical and Real-world Defined Pulmonary Arterial Hypertension (PAH) Cohorts in Electronic Health Records (EHR) From the Mayo Clinic

被引：0
|
作者：
Dubrock, H. M. [1 ]
Carpenter, C. L. [2 ]
Carlson, K. [2 ]
Doddahonnaiah, D. [2 ]
Sasson, D. [2 ]
Silvert, E. [2 ]
Sandros, M. [3 ]
Tobore, T. [3 ]
Wagner, T. E. [2 ]
Bettencourt, K. [3 ]
机构：
[1] Mayo Clin, Div Pulm Crit Care & Sleep Med, Rochester, MN USA
[2] Nference, Cambridge, MA USA
[3] Actel Pharmaceut US Inc, Titusville, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6453
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Real-world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database
    Omura, Junichi
    Kitahara, Kazuki
    Takano, Masashi
    Idehara, Koki
    Kim, Seok-Won
    PULMONARY CIRCULATION, 2023, 13 (03)
  • [22] Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE
    Muller, Audrey
    Escribano-Subias, Pilar
    Fernandes, Catarina C.
    Fontana, Martina
    Lange, Tobias J.
    Soderberg, Stefan
    Gaine, Sean
    ADVANCES IN THERAPY, 2024, 41 (03) : 1103 - 1119
  • [23] Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE
    Audrey Muller
    Pilar Escribano-Subias
    Catarina C. Fernandes
    Martina Fontana
    Tobias J. Lange
    Stefan Söderberg
    Sean Gaine
    Advances in Therapy, 2024, 41 : 1103 - 1119
  • [24] CLINICAL PRACTICE FOR ACUTE VASOREACTIVITY TESTING IN PEDIATRIC PULMONARY ARTERIAL HYPERTENSION IN REAL-WORLD
    Wu, Y.
    Hua, L.
    Yan, X.
    Peng, F.
    Tan, J.
    Gao, X.
    CHEST, 2022, 161 (06) : 386A - 386A
  • [25] Prevalence, Incidence, and Characterization of LIGHT Chain Amyloidosis in the USA: A Real-World Analysis Utilizing Electronic Health Records (EHR)
    Laires, Pedro A.
    Evans, Jennifer
    Thompson, Jeffrey
    Manwani, Richa
    Mudumby, Pallavi
    Field, Michelle
    Fang, Shona
    BLOOD, 2023, 142
  • [26] Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD): Real-world experience from EXPOSURE
    Gaine, Sean
    Escribano-Subias, Pilar
    Muller, Audrey
    Fernandes, Catarina C.
    Fontana, Martina
    Remenova, Tatiana
    Soderberg, Stefan
    Lange, Tobias J.
    PULMONARY CIRCULATION, 2024, 14 (03)
  • [27] Real-World Upfront Combination Therapy with Macitentan and Tadalafil in Pulmonary Arterial Hypertension (PAH): Data from the Combined OPUS and OrPHeUS Datasets
    Chin, K. M.
    Channick, R.
    McLaughlin, V. V.
    Melendres-Groves, L.
    Flynn, M.
    Leroy, S.
    Wetherill, G.
    Kim, N. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [28] Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Finland Between 2008 and 2020 (FINPAH) - A Descriptive Real-World Cohort Study
    Pentikainen, M. O.
    Simonen, P.
    Tuunanen, H.
    Leskela, P.
    Harju, T.
    Jaaskelainen, P.
    Soini, E.
    Asseburg, C.
    Mankinen, P.
    Wennerstrom, C.
    Puhakka, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S325 - S326
  • [29] Health Outcomes in Pulmonary Arterial Hypertension Patients With COVID-19: A Real-world Analysis
    Feldman, Jeremy
    Wilson, Melisa
    Kantorovich, Alexander
    DeRuiter, Alexander
    Schreur, Kevin
    Classi, Peter
    Nelsen, Andrew
    CIRCULATION, 2020, 142
  • [30] Using Real-World Data to Optimize Strategic Planning for Pulmonary Arterial Hypertension Clinical Trials
    Shah, Monica R.
    Oakes, Scott
    Goins, Monica L.
    Kawasaki, Nobu
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S59 - S59
12345